Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Bionano Genomics's ebitda for the twelve months ending Jun 30, 2026 was -$22.87M. For fiscal 2025 it was -$23.81M. The highest annual figure on record is -$19.09M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.81M | – |
| FY2024 | Dec 31, 2024 | -$89.96M | – |
| FY2023 | Dec 31, 2023 | -$201.54M | – |
| FY2022 | Dec 31, 2022 | -$122.08M | – |
| FY2021 | Dec 31, 2021 | -$73.75M | – |
| FY2020 | Dec 31, 2020 | -$37.07M | – |
| FY2019 | Dec 31, 2019 | -$24.75M | – |
| FY2018 | Dec 31, 2018 | -$19.09M | – |
| FY2017 | Dec 31, 2017 | -$21.71M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.59M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.16M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.42M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.03M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$38.27M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.03M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$21.36M | – |
| Q3 FY2023 | Sep 30, 2023 | -$109.59M | – |
| Q2 FY2023 | Jun 30, 2023 | -$35.94M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.65M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.76M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$29.81M | – |
| Q1 FY2022 | Mar 31, 2022 | -$27.73M | – |
| Q4 FY2021 | Dec 31, 2021 | -$26.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$20.15M | – |
| Q2 FY2021 | Jun 30, 2021 | -$15.96M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.56M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.14M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.47M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.85M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.41M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.58M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.92M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.95M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.63M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.94M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.70M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.79M | – |
See a number that looks wrong?